Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Victor Sierra, Lulu Bravo, Eduardo López-Medina, Felix Espinoza, Pope Kosalaraksa, Dulanie Gunasekera, Asvini D Fernando, Edson Duarte Moreira, V Pujitha Wickramasinghe, Delia Yu, Edith Johana Rodriguez-Arenales, Suely Tuboi, Maria Theresa Alera, Hector Velásquez, Luis Martinez Vargas, Charissa Borja-Tabora, Shibadas Biswal, Derek Wallace, Xavier Saez-Llorens, Astrid Borkowski, Inge LeFevre, Svetlana Bizjajeva, Martina Rauscher, Ian Escudero, Pedro Garbes, Yanee Hutagalung
Lancet (London, England) 2020;395(10234):1423-1433